Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104628584A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104628584A reveals a mild synthesis route for dapoxetine. Achieve 99.9% purity with reduced toxicity and significant cost reduction in API manufacturing.